| Literature DB >> 30301902 |
Suresh Mehata1, Nipun Shrestha2, Ranju Kumari Mehta3, Bihungum Bista3, Achyut Raj Pandey3, Shiva Raj Mishra4,5.
Abstract
Metabolic syndrome (MetS) increases the risk of cardiovascular diseases and diabetes mellitus. This study is designed to assess the prevalence and determinants of MetS among Nepalese adults from a nationally representative study. This study is based on Stepwise Approach to Surveillance (STEPS) Survey from Nepal. This survey was done among 4200 adults aged 15-69 years from 210 clusters selected proportionately across Nepal's three ecological zones (Mountain, Hill and Terai). Subsequently, using systematic sampling, twenty households per cluster and one participant per household were selected. The overall prevalence of MetS is 15% and 16% according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria respectively. A triad of low HDL-C, abdominal obesity and high BP was the most prevalent (8.18%), followed by abdominal obesity, low HDL-C cholesterol and high triglycerides (8%). Less than two percent of participants had all the five components of the syndrome and 19% of participants had none. The prevalence steadily rose across the age group with adults aged 45-69 years having the highest prevalence (28-30%) and comparable prevalence across two definitions of MetS. A notably high burden for females, urban, hill or Terai resident were seen among other factors.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30301902 PMCID: PMC6177417 DOI: 10.1038/s41598-018-33177-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Frequency distribution of various combinations of components of metabolic syndrome among the participants (N = 3729).
| Both sexes (N = 3729) | Male (N = 1190) | Female (N = 2539) | P | |
|---|---|---|---|---|
| Abdominal obesity* | 27.47 | 18.03 | 36.49 | <0.001 |
| Raised triglycerides (TRI)ɫ | 25.26 | 31.78 | 19.50 | <0.001 |
| Low HDL cholesterolǂ | 70.72 | 61.22 | 79.29 | <0.001 |
| Raised fasting blood glucose§ | 17.59 | 21.36 | 13.71 | <0.001 |
| High blood pressure¶ | 26.28 | 30.84 | 20.18 | <0.001 |
| 0 or <3 components | 78.85 | 79.03 | 78.67 | 0.923 |
| Low HDL + TRI + high BP | 6.90 | 6.41 | 9.18 | 0.014 |
| Low HDL + TRI + abdominal obesity | 7.83 | 1.04 | 5.28 | 0.011 |
| Low HDL + TRI + abdominal obesity + high BP | 3.92 | 3.91 | 3.93 | 0.977 |
| Low HDL + TRI + abdominal obesity + high BP + FG | 1.30 | 0.96 | 1.64 | 0.007 |
| Low HDL + abdominal obesity + high BP | 8.18 | 6.85 | 9.45 | 0.010 |
| Low HDL + abdominal obesity + FG | 4.74 | 3.40 | 6.02 | 0.003 |
| TRI + abdominal obesity + high BP + FG | 1.82 | 1.72 | 1.92 | 0.647 |
| Abdominal obesity + FG + High BP | 3.62 | 3.71 | 3.52 | 0.768 |
*Abdominal obesity (waist ≥90 cm in men or ≥80 cm in women).
ɫRaised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).
ǂLow HDL cholesterol (<40 mg/dL in men; <50 mg/dL in women or specific treatment for this lipid abnormality).
§Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).
¶High BP (systolic BP ≥130 or diastolic BP ≥85 mm Hg or treatment of previously diagnosed hypertension).
BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein.
Figure 1Prevalence of various components of metabolic syndrome among participants aged 15–69 years.
Mean number various components of metabolic syndrome and independent effects of covariates on metabolic syndrome components clustering in individuals.
| Age group | Un-weighted | Mean number of | ARR*a | P |
|---|---|---|---|---|
| 15–29 | 831 | 1.28 (1.20–1.36) | 1 | |
| 30–44 | 1,410 | 1.85 (1.76–1.94) | 1.28 (1.19–1.38) | <0.001 |
| 45–69 | 1,488 | 2.14 (2.04–2.24) | 1.52 (1.41–1.63) | <0.001 |
|
| ||||
| Male | 1,190 | 1.64 (1.54–1.74) | 1 | |
| Female | 2,539 | 1.71 (1.64–1.77) | 1.03 (0.98–1.09) | 0.247 |
|
| ||||
| No formal schooling | 1,662 | 1.77 (1.68–1.86) | 1 | |
| Primary | 917 | 1.67 (1.56–1.78) | 1.03 (0.97–1.09) | 0.325 |
| Secondary | 705 | 1.60 (1.47–1.74) | 1.07 (1.00–1.16) | 0.057 |
| Higher | 445 | 1.61 (1.49–1.74) | 1.12 (1.03–1.23) | 0.011 |
|
| ||||
| Never married | 299 | 1.24 (1.12–1.36) | 1 | |
| Currently married | 3,222 | 1.77 (1.70–1.84) | 1.00 (0.90–1.12) | 0.950 |
| Divorced/Widowed/Separated | 207 | 1.79 (1.58–2.00) | 0.89 (0.78–1.03) | 0.111 |
|
| ||||
| Dalits | 317 | 1.76 (1.61–1.92) | 1 | |
| Disadvantaged Janajatis | 1,165 | 1.60 (1.51–1.69) | 0.91 (0.82–1.01) | 0.069 |
| Disadvantaged non-Dalit Terai caste groups | 296 | 1.50 (1.33–1.66) | 0.88 (0.77–0.99) | 0.036 |
| Religious minorities | 46 | 2.00 (1.53–2.47) | 1.06 (0.83–1.34) | 0.640 |
| Relatively advantaged Janajatis | 287 | 1.88 (1.61–2.15) | 0.88 (0.77–1.00) | 0.050 |
| Upper caste groups | 1,618 | 1.70 (1.59–1.80) | 0.88 (0.80–0.98) | 0.015 |
|
| ||||
| Mountain | 260 | 1.56 (1.30–1.82) | 1 | |
| Hill | 1,568 | 1.76 (1.64–1.88) | 0.99 (0.83–1.17) | 0.881 |
| Terai | 1,901 | 1.62 (1.54–1.70) | 0.98 (0.83–1.15) | 0.798 |
|
| ||||
| Rural | 3,022 | 1.60 (1.53–1.67) | 1 | |
| Urban | 707 | 1.99 (1.81–2.16) | 1.13 (1.05–1.21) | 0.001 |
|
| ||||
| No | 3,051 | 1.68 (1.61–1.76) | 1 | |
| Yes | 678 | 1.63 (1.51–1.74) | 0.96 (0.89–1.03) | 0.244 |
|
| ||||
| No | 3,663 | 1.67 (1.61–1.74) | 1 | |
| Yes | 66 | 1.70 (1.30–2.10) | 1.10 (0.87–1.40) | 0.417 |
|
| ||||
| No | 43 | 1.78 (1.36–2.20) | 1 | |
| Yes | 3,686 | 1.67 (1.60–1.74) | 1.07 (0.93–1.23) | 0.330 |
|
| ||||
| No | 3,580 | 1.67 (1.60–1.73) | 1 | |
| Yes | 133 | 1.90 (1.64–2.16) | 1.04 (0.94–1.16) | 0.419 |
|
| ||||
| No | 1,056 | 1.29 (1.21–1.36) | 1 | |
| Yes | 2,673 | 1.94 (1.86–2.02) | 1.35 (1.27–1.43) | <0.001 |
|
| ||||
| <25 | 2,773 | 1.42 (1.35–1.48) | 1 | |
| 25–30 | 763 | 2.50 (1.39–2.62) | 1.51 (1.43–1.60) | <0.001 |
| >30 | 193 | 2.95 (2.72–3.19) | 1.65 (1.52–1.78) | <0.001 |
|
|
| 1.67 (1.61–1.74) | ||
*The number of components of metabolic syndrome was the dependent variable. Each Relative Risk (RR) reflects the risk of having x or more components versus having fewer against the risk in the reference group. Hence, the Adjusted RR (ARR) represents the average effect of the covariate on the risk of having x number of components or more.
aARR have been adjusted for all variables listed.
Prevalence of metabolic syndrome by demographic and clinical risk factors.
| Un-weighted | ATP III | IDF | |
|---|---|---|---|
|
| |||
| 15–29 | 831 | 4.71 | 6.06 |
| 30–44 | 1,410 | 18.3 | 19.43 |
| 45–69 | 1,488 | 29.97 | 28.27 |
|
| <0.001 | <0.001 | |
|
| |||
| Male | 1,190 | 15.30 | 13.42 |
| Female | 2,539 | 15.43 | 18.10 |
|
| 0.923 | 0.002 | |
|
| |||
| No formal schooling | 1,662 | 17.87 | 19.01 |
| Primary | 917 | 15.5 | 16.43 |
| Secondary | 705 | 15.39 | 14.31 |
| Higher | 445 | 11.05 | 11.80 |
|
| 0.021 | <0.001 | |
|
| |||
| Never married | 299 | 3.79 | 3.19 |
| Currently married | 3,222 | 17.83 | 18.66 |
| Divorced/Widowed/Separated | 207 | 22.52 | 19.99 |
|
| <0.001 | <0.001 | |
|
| |||
| Dalits | 317 | 15.31 | 17.11 |
| Disadvantaged Janajatis | 1,165 | 13.29 | 13.05 |
| Disadvantaged non-Dalit Terai caste groups | 296 | 10.99 | 12.39 |
| Religious minorities | 46 | 25.25 | 16.32 |
| Relatively advantaged Janajatis | 287 | 23.04 | 23.70 |
| Upper caste groups | 1,618 | 16.12 | 16.83 |
|
| 0.007 | 0.020 | |
|
| |||
| Mountain | 260 | 12.45 | 5.56 |
| Hill | 1,568 | 19.09 | 18.36 |
| Terai | 1,901 | 12.65 | 14.96 |
|
| 0.002 | 0.001 | |
|
| |||
| Rural | 3,022 | 13.42 | 13.75 |
| Urban | 707 | 23.42 | 24.36 |
|
| <0.001 | <0.001 | |
|
| |||
| No | 3,051 | 15.68 | 16.69 |
| Yes | 678 | 13.99 | 12.00 |
|
| 0.405 | 0.012 | |
|
| |||
| No | 3,663 | 15.25 | 15.96 |
| Yes | 66 | 20.72 | 9.23 |
|
| <0.458 | 0.196 | |
|
| |||
| No | 43 | 12.84 | 17.83 |
| Yes | 3,686 | 15.39 | 15.79 |
|
| 0.665 | 0.786 | |
|
| |||
| No | 3,580 | 15.04 | 15.71 |
| Yes | 133 | 24.95 | 18.87 |
|
| 0.011 | 0.403 | |
|
| |||
| No | 1,056 | 7.3 | 2.94 |
| Yes | 2,673 | 20.93 | 24.70 |
|
| <0.001 | <0.001 | |
|
| |||
| <25 | 2,773 | 8.76 | 6.85 |
| 25-<30 | 763 | 33.83 | 43.84 |
| ≥30 | 193 | 61.2 | 64.71 |
|
| <0.001 | <0.001 | |
|
|
|
|
|
Figure 2Prevalence of the metabolic syndrome according to ATP III and IDF definitions.
Univariate and multivariate analyses of demographic and clinical risk factors for metabolic syndrome.
| ATP III Criteria | IDF Criteria | |||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95%CI | OR# | 95%CI | OR | 95%CI | OR# | 95%CI | |
|
| ||||||||
| 15–29 | 1 | 1 | 1 | 1 | ||||
| 30–44 | 4.53 | 2.81–7.32** | 3.04 | 1.84–5.03** | 3.74 | 2.58–5.41** | 2.07 | 1.31–3.25* |
| 45–69 | 8.66 | 5.46–13.73** | 7.08 | 4.26–11.78** | 6.11 | 4.31–8.65** | 4.52 | 2.91–7.03** |
|
| ||||||||
| | 1 | 1 | 1 | |||||
| | 1.01 | 0.82–1.24 | 0.97 | 0.75–1.26 | 1.43 | 1.14–1.79* | 1.44 | 1.05–1.97* |
|
| ||||||||
| No formal schooling | 1 | 1 | 1 | |||||
| Primary | 0.84 | 0.65–1.10 | 1.11 | 0.82–1.51 | 0.84 | 0.65–1.07 | 1.08 | 0.79–1.49 |
| Secondary | 0.84 | 0.62–1.13 | 1.53 | 1.07–2.19* | 0.71 | 0.54–0.93* | 1.11 | 0.76–1.63 |
| Higher | 0.57 | 0.41–0.80* | 1.03 | 0.65–1.63 | 0.57 | 0.41–0.79* | 0.90 | 0.57–1.41 |
|
| ||||||||
| Never married | 1 | 1 | ||||||
| Currently married | 5.5 | 2.37–12.79** | 1.25 | 0.50–3.12 | 6.97 | 3.30–14.72** | 1.72 | 0.73–4.08 |
| Divorced/Widowed/Separated | 7.37 | 2.98–18.21** | 1.03 | 0.39–2.73 | 7.59 | 3.44–16.75** | 1.12 | 0.44–2.85 |
|
| ||||||||
| Dalits | 1 | 1 | 1 | 1 | ||||
| Disadvantaged Janajatis | 0.85 | 0.55–1.31 | 0.79 | 0.48–1.33 | 0.73 | 0.46–1.14 | 0.58 | 0.34–1.01 |
| Disadvantaged non-Dalit Terai caste groups | 0.68 | 0.39–1.19 | 0.78 | 0.45–1.34 | 0.69 | 0.37–1.26 | 0.64 | 0.32–1.26 |
| Religious minorities | 1.87 | 0.87–4.01 | 1.99 | 0.76–5.18 | 0.94 | 0.33–2.74 | 0.65 | 0.16–2.63 |
| Relatively advantaged Janajatis | 1.66 | 0.97–2.84 | 0.73 | 0.42–1.28 | 1.50 | 0.88–2.59 | 0.65 | 0.36–1.19 |
| Upper caste groups | 1.06 | 0.70–1.61 | 0.76 | 0.48–1.20 | 0.98 | 0.63–1.52 | 0.61 | 0.36–1.06 |
|
| ||||||||
| Mountain | 1 | 1 | 1 | 1 | ||||
| Hill | 1.66 | 0.89–3.10 | 1.04 | 0.49–2.18 | 3.82 | 2.00–7.31** | 2.41 | 1.04–5.63* |
| Terai | 1.02 | 0.56–1.87 | 0.75 | 0.36–1.55 | 2.99 | 1.57–5.70* | 2.64 | 1.14–6.11* |
|
| ||||||||
| Rural | 1 | 1 | 1 | 1 | ||||
| Urban | 1.97 | 1.44–2.71** | 1.56 | 1.14–2.13* | 2.02 | 1.48–2.76** | 1.56 | 1.14–2.13* |
|
| ||||||||
| No | 1 | 1 | ||||||
| Yes | 0.87 | 0.64–1.20 | 0.76 | 0.51–1.13 | 0.68 | 0.50–0.92* | 0.71 | 0.50–1.01 |
|
| ||||||||
| No | 1 | 1 | 1 | 1 | ||||
| Yes | 1.45 | 0.54–3.93 | 1.80 | 0.46–7.03 | 0.54 | 0.20–1.41 | 0.69 | 0.21–2.28 |
|
| ||||||||
| No | 1 | 1 | 1 | 1 | ||||
| Yes | 1.24 | 0.47–3.23 | 2.21 | 0.75–6.50 | 0.86 | 0.30–2.49 | 1.24 | 0.42–3.63 |
|
| ||||||||
| No | 1 | 1 | 1 | 1 | ||||
| Yes | 1.88 | 1.15–3.08* | 1.48 | 0.89–2.47 | 1.25 | 0.74–2.10 | 0.93 | 0.54–1.59 |
|
| ||||||||
| No | 1 | 1 | 1 | |||||
| Yes | 3.36 | 2.40–4.70** | 2.50 | 1.79–3.50** | 14.46 | 10.48–19.95** | 8.18 | 5.93–11.29** |
|
| ||||||||
| <25 | 1 | 1 | 1 | 1 | ||||
| 25–30 | 5.32 | 4.06–6.97** | 3.74 | 2.79–5.02** | 10.61 | 8.13–13.84** | 7.82 | 5.78–10.78** |
| >30 | 16.42 | 10.84–24.87** | 9.44 | 6.03–14.78** | 24.92 | 16.02–38.77** | 14.03 | 8.71–22.60** |
#Adjusted relative risk have been adjusted for all variables listed.
*p < 0.05; **P < 0.001.
Showing the definition of variables used in the study.
| Variable | Definition/measurements |
|---|---|
| Physical measurements | Height and weight were measured and body mass index (BMI) calculated as weight (kg.)/height (m2). Portable standard stature scale was used to measure height. Footwear (shoes, slippers, sandals) and hat were removed while measuring height. Respondents stood on a flat surface facing the interviewer with their feet together and heels against the backboard with knees straight. They were asked to look straight ahead and not tilt their head up, making sure that their eyes were at the same level as their ears. Height was recorded in centimetres. |
| Blood Pressure measurements | Blood pressure was measured with a digital, automated blood pressure monitor (OMRON digital device) with medium cuff. Before taking the measurements, participants were asked to sit quietly and rest for 15 minutes with legs uncrossed. Three readings of the systolic and diastolic blood pressure were obtained using standard protocol. Participants rested for three minutes between each reading. The mean of the second and third readings was calculated. |
| Biochemical measurements | A separate mobile laboratory setting was used to collect biochemical data. The mobile laboratory contained all of the logistics and human resources required for the set up including a semi auto analyser and all of the chemicals required for blood glucose testing and lipid profile measurement. To ensure that the cold chain was maintained for the collected samples and for the preservation of the chemicals used for the tests, continuous electricity was ensured with an electric generator and refrigerator. |
| Metabolic syndrome [NCEP ATP III criteria][ | Any three of the five criteria below: |
| Metabolic syndrome [IDF criteria][ | Central obesity (waist circumference: ≥90 cm (Male), ≥80 cm (Female)) plus two of the following criteria below: |
| Current smoking | Those who smoked in the past 30 days were considered as a current smoker. |
| Harmful Alcohol consumption | Detailed information on number of standard drinks consumed and frequency of consuming standard drinks in the last 30 days was obtained from current users. One standard drinks was considered as 10 grams of ethanol, the number of standard drinks was calculated using the amount consumed by participants. |
| Insufficient fruits and vegetable intake | Information on fruit and vegetables consumption in a typical week. Also, the number of servings of fruit and vegetables consumed on average per day. The amount of fruit and vegetables was measured using pictorial show cards and measuring cups (one standard serving of fruit or vegetables equals 80 grams). |
| Low Physical activity | Global Physical Activity Questionnaire (GPAQ) was used to assess physical activities[ |
| Abnormal waist to hip ratio[ | Abnormal waist to hip ratio is defined as a waist–hip ratio >0.90 for males and >0.85 for females. |